The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Health-care companies rose as earnings continued to come in strong. AbbVie shares rose after the drugmaker posted earnings ahead of Wall Street targets.

Shares of Novavax Inc. NVAX shed 5.66% to $6.67 Friday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP rising 1.26% to 17,382.94 ...

Novavax faces a setback as the FDA requests an additional trial for COVID-19 vaccine approval. Read more here.

(Reuters) -Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after ...

At some point within the first hour of waking up, expose yourself to natural light, preferably by taking a quick walk, Kaur ...

Novavax shares declined after a Wall Street Journal report that federal regulators are asking the company to complete an additional randomized clinical trial on its Covid-19 vaccine, according to ...

EDT Novavax (NVAX) asked by FDA to complete additional COVID trial, WSJ saysStay Ahead of the Market: Discover outperforming stocks and ...

EDT Novavax (NVAX) down 10% after WSJ report on FDA request for additional vaccine trialStay Ahead of the Market: Discover outperforming ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company ...

Here’s what several large drugmakers said about tariffs when reporting earnings this morning: Merck made a small downward ...